Abstract:
Using a novel approach, we have expressed and generated aqueous-soluble recombinant E. coli derived VP1 (rVP1) of foot-and-mouth disease virus (FMDV). We have found that rVP1 of FMDV causes apoptosis of human cancer by binding to cellular integrins through its RGD motif and modulating Akt signaling pathway. rVP1 is 1,000 fold more potent than most RGD containing oligopeptides. It induces apoptosis of a variety of cancer cells including those of breast, prostate, lung, colorectal, leukemia, β lymphoma and ovary.
Fields of Application:
Cancer. Vaccine.
Advantages when compared to the existing technologies:
1. The efficacy of our apoptotic polypeptide is much better than RGD or RGD containing oligopeptides. Its mechanism of action is known to be via binding of integrin and deactivation of Akt pathway. It shows even higher efficacy in many cancer cells that are resistant to the current available anti-cancer agents. 2. Low toxicity 3. Easily production
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you
IP Status:Issued US 7323546B2; US7488800B2; US7700730B2;TW I 337184; EP 2465531 B1; EP1765392
